BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 30429071)

  • 21. [Pelvic Inflammatory Diseases: Updated Guidelines for Clinical Practice - Short version].
    Brun JL; Castan B; de Barbeyrac B; Cazanave C; Charvériat A; Faure K; Mignot S; Verdon R; Fritel X; Graesslin O
    Gynecol Obstet Fertil Senol; 2019 May; 47(5):398-403. PubMed ID: 30880245
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Consensus of best practice in intrauterine contraception in France.
    Serfaty D; Bénézech JP; Heckel S; De Reilhac P
    Eur J Contracept Reprod Health Care; 2019 Aug; 24(4):305-313. PubMed ID: 31204843
    [No Abstract]   [Full Text] [Related]  

  • 23. [Contraception for women after 40: CNGOF Contraception Guidelines].
    Lambert M; Begon E; Hocké C
    Gynecol Obstet Fertil Senol; 2018 Dec; 46(12):865-872. PubMed ID: 30424983
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Intrauterine contraception in nulliparous women].
    Prilepskaia VN; Mezhevitinova EA
    Akush Ginekol (Mosk); 1991 Apr; (4):5-8. PubMed ID: 1862876
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of spontaneous preterm birth: Guidelines for clinical practice from the French College of Gynaecologists and Obstetricians (CNGOF).
    Sentilhes L; Sénat MV; Ancel PY; Azria E; Benoist G; Blanc J; Brabant G; Bretelle F; Brun S; Doret M; Ducroux-Schouwey C; Evrard A; Kayem G; Maisonneuve E; Marcellin L; Marret S; Mottet N; Paysant S; Riethmuller D; Rozenberg P; Schmitz T; Torchin H; Langer B
    Eur J Obstet Gynecol Reprod Biol; 2017 Mar; 210():217-224. PubMed ID: 28068594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contraception Update: Intrauterine Devices.
    Antell K; Deshmukh P; Brown EJ
    FP Essent; 2017 Nov; 462():20-24. PubMed ID: 29172412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infection risk and intrauterine devices.
    Martínez F; López-Arregui E
    Acta Obstet Gynecol Scand; 2009; 88(3):246-50. PubMed ID: 19172421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Post-abortion contraception].
    Ohannessian A; Jamin C
    J Gynecol Obstet Biol Reprod (Paris); 2016 Dec; 45(10):1568-1576. PubMed ID: 27773547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The intrauterine contraceptive device.
    Barwin BN; Tuttle S; Jolly EE
    Can Med Assoc J; 1978 Jan; 118(1):53-8. PubMed ID: 620385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intrauterine devices in nulliparous women.
    Petersen KR; Brooks L; Jacobsen B; Skouby SO
    Adv Contracept; 1991 Dec; 7(4):333-8. PubMed ID: 1776557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pelvic inflammatory diseases: Updated French guidelines.
    Brun JL; Castan B; de Barbeyrac B; Cazanave C; Charvériat A; Faure K; Mignot S; Verdon R; Fritel X; Graesslin O; ;
    J Gynecol Obstet Hum Reprod; 2020 May; 49(5):101714. PubMed ID: 32087306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diagnosis and management of uterine perforations after intrauterine device insertion: a report of 11 cases].
    Boyon C; Giraudet G; Guérin Du Masgenêt B; Lucot JP; Goeusse P; Vinatier D
    Gynecol Obstet Fertil; 2013 May; 41(5):314-21. PubMed ID: 22818520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complications of use of intrauterine devices among HIV-1-infected women.
    Sinei SK; Morrison CS; Sekadde-Kigondu C; Allen M; Kokonya D
    Lancet; 1998 Apr; 351(9111):1238-41. PubMed ID: 9643743
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Intrauterine devices].
    Delavest P; Engelmann P
    Rev Prat; 1980 Dec; 30(57):3981-2, 3985-7. PubMed ID: 7455547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prevention of spontaneous preterm birth (excluding preterm premature rupture of membranes): Guidelines for clinical practice - Text of the Guidelines (short text)].
    Sentilhes L; Sénat MV; Ancel PY; Azria E; Benoist G; Blanc J; Brabant G; Bretelle F; Brun S; Doret M; Ducroux-Schouwey C; Evrard A; Kayem G; Maisonneuve E; Marcellin L; Marret S; Mottet N; Paysant S; Riethmuller D; Rozenberg P; Schmitz T; Torchin H; Langer B
    J Gynecol Obstet Biol Reprod (Paris); 2016 Dec; 45(10):1446-1456. PubMed ID: 27836377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-acting reversible contraception: a review in special populations.
    Prescott GM; Matthews CM
    Pharmacotherapy; 2014 Jan; 34(1):46-59. PubMed ID: 24130075
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adolescent experience with intrauterine device insertion and use: a retrospective cohort study.
    Bayer LL; Jensen JT; Li H; Nichols MD; Bednarek PH
    Contraception; 2012 Nov; 86(5):443-51. PubMed ID: 22560185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Health risks of intrauterine contraception (author's transl)].
    Keith LG; Berger GS; Edelman DA
    Contracept Fertil Sex (Paris); 1983 Jun; 11(6):801-8. PubMed ID: 12338737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Initiation and continuation of long-acting reversible contraception in the United States military healthcare system.
    Chiles DP; Roberts TA; Klein DA
    Am J Obstet Gynecol; 2016 Sep; 215(3):328.e1-9. PubMed ID: 27005514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insertion and removal of intrauterine devices.
    Kovacs GT
    Aust Fam Physician; 1990 May; 19(5):703-4. PubMed ID: 2346424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.